Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
My New Book is Now A Best Seller | Order Now My New Book is Now A Best Seller | Order Now

FDA Considers OTC Statin Status For Mevacor

  • December 28, 2004

A little more than a year ago, there was talk in the business press drugmakers Bristol Myers-Squibb and Merck would file separate requests with the FDA to sell their statin drugs, Pravachol and Mevacor respectively, over the counter. That intention has finally become a reality, with Merck's application being considered by an advisory committee Jan. 13-14 and Bristol Myers-Squibb announcing it will seek the same status for Pravachol. Four years ago, Merck's request was denied because...